- Home
- PHVS vs VRNT Comparison
PHVS vs VRNT Comparison
Compare PHVS & VRNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PHVS
- VRNT
- Stock Information
- Founded
- PHVS 2015
- VRNT 1994
- Country
- PHVS Switzerland
- VRNT United States
- Employees
- PHVS N/A
- VRNT N/A
- Industry
- PHVS Biotechnology: Pharmaceutical Preparations
- VRNT EDP Services
- Sector
- PHVS Health Care
- VRNT Technology
- Exchange
- PHVS Nasdaq
- VRNT Nasdaq
- Market Cap
- PHVS 980.9M
- VRNT 1.1B
- IPO Year
- PHVS 2021
- VRNT N/A
- Fundamental
- Price
- PHVS $22.32
- VRNT $21.18
- Analyst Decision
- PHVS Buy
- VRNT Buy
- Analyst Count
- PHVS 6
- VRNT 6
- Target Price
- PHVS $37.17
- VRNT $30.33
- AVG Volume (30 Days)
- PHVS 33.8K
- VRNT 2.7M
- Earning Date
- PHVS 08-13-2025
- VRNT 09-03-2025
- Dividend Yield
- PHVS N/A
- VRNT N/A
- EPS Growth
- PHVS N/A
- VRNT 79.53
- EPS
- PHVS N/A
- VRNT 0.84
- Revenue
- PHVS N/A
- VRNT $896,006,000.00
- Revenue This Year
- PHVS N/A
- VRNT $7.65
- Revenue Next Year
- PHVS N/A
- VRNT $5.54
- P/E Ratio
- PHVS N/A
- VRNT $24.58
- Revenue Growth
- PHVS N/A
- VRNT N/A
- 52 Week Low
- PHVS $11.51
- VRNT $14.15
- 52 Week High
- PHVS $25.76
- VRNT $37.31
- Technical
- Relative Strength Index (RSI)
- PHVS 73.31
- VRNT 61.29
- Support Level
- PHVS $17.63
- VRNT $18.50
- Resistance Level
- PHVS $19.00
- VRNT $22.42
- Average True Range (ATR)
- PHVS 1.20
- VRNT 1.31
- MACD
- PHVS 0.35
- VRNT 0.29
- Stochastic Oscillator
- PHVS 92.15
- VRNT 74.26
About PHVS Pharvaris N.V.
Pharvaris NV is a late-stage biopharmaceutical company which is engaged in developing novel, oral bradykinin B2 receptor antagonists to prevent and treat HAE attacks. By directly pursuing this clinically therapeutic target with novel small molecules, With positive data in both Phase 2 prophylaxis and studies in HAE, Pharvaris is developing deucrictibant. Pharvaris is currently enrolling a pivotal Phase 3 study for the treatment of HAE attacks and plans to initiate a pivotal Phase 3 study of deucrictibant for the prevention of HAE attacks.
About VRNT Verint Systems Inc.
Verint Systems Inc with its subsidiaries, helps brands provide Boundless customer experience (CX) automation. AI offers a solution, and that's where Verint comes in. It empowers brands with groundbreaking AI via a next-gen open platform. Its Verint Open Platform helps organizations increase CX automation to achieve their strategic objectives and realize ROI. Geographically, it derives a majority of its revenue from the United States.